Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
View the full immuno-oncology abstracts collection!
Read the most innovative science on novel CAR designs, cancer immunotherapy, B cell malignancies, genome and epigenome editing, and more.
View the Abstracts PDF
#20 - Saliogase-based Gene Coding Technology, a Non-Viral Genome Engineering Platform for Efficient CAR-T Generation for Cancer Immunotherapy Francisco Navarro, PhD (SalioGen Therapeutics)
#8 - Mechanistic Study and Fine Tuning of CD8ab-CD28 Chimeric Co-receptor (CCR) for TCR-T Cell Function Enhancement Tzu-Hao Tang (Fred Hutchinson Cancer Center)
#23 - Leveraging Lentivirus Biology to Achieve Dual Car Expression Diana A. Vedenova (Sana Biotechnology)
#9 - Advancing Adoptive T Cell Therapy against Cancer through the Development of Dual Costimulatory Receptors Ryma RT. Toumi, PhD (Seattle Children’s Research Institute)
#13 - Unlocking the Potential of Allogeneic Vδ2 T Cells for Ovarian Cancer Therapy Through CD16 Biomarker Selection and CAR/IL-15 Engineering Derek Lee, PhD (UCLA)
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico